Building on his previous article about practical steps to AI production, Ali Bovis at Version 1 delves into the importance of establishing essential trust in public sector AI projects.
VolkerSmart Technologies introduce their work in decarbonising the NHS, discussing their role in lessening transport emissions with their numerous services.
Matthew Bradfield, Managing Director at Fairford Medical Ltd conducts a case study of Liverpool University Hospitals NHS Foundation Trust and its new CT scanner
In...
More than half of neurointerventionalists, neurosurgeons, neurologists and radiologists are currently experiencing burnout as a result of provider shortages, covering multiple hospitals simultaneously, and increasing demand for emergency stroke care, and this is only expected to get worse.
Pierce Mahne, Head of Corporate Accounts - UK at ACT Commodities, explains how ACT specializes in sourcing renewable energy along with environmental products proving...
Graham Watson, Executive Chair at InnoScot Health, explains how the firm’s special 20th anniversary celebrates international healthcare innovation success.
Dr Chuk Anyaegbuna, clinical service lead at Koa Health, and clinical psychologist, Dr Tania Johnston discuss how technology can support the current delivery system and improve access to mental health services.
Sectors such as construction are still not able to carry out the necessary measures to fight climate change, will implementing AI-based tech help change this?
CEO of ViewMind Inc, Mark Edwards, discusses the cognitive effects of Long COVID, aiming to understand the science behind brain fog and other COVID symptoms.
Stuart Steel, Founding Director of Insimbi Consulting Ltd, explains how harnessing modernised ETL processes and DPA as part of your digital transformation strategy can unleash the full potential of your data, drive significant cost and time savings and elevate your business above the competition.
Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA and APAC at PTC Therapeutics explores how preparing Europe for a new generation of innovative therapies has the potential to transform the lives of patients.
